Shaker – Edition #16 (copy)

SHAKER: Genopole's early-stage support program aspiring entrepreneurs with a biotech idea in healthcare💊and bioeconomy🌿

person

Participation
individuelle

Traduire la page

Become an BIOENTREPRENEUR with Shaker

Genopole's early-stage support program
aspiring entrepreneurs
with a biotech idea in healthcare💊and bioeconomy🌿

How does it work? 💡

Duration: 6 months

No IP Acquisition

No Equity Taken

A dual SCIENCE🧪 & BUSINESS 📁 support:

Scientific support 🧪

24/7 access to a fully equipped shared biotech laboratory at the Pépinière Genopole
Financial package for purchasing consumables/reagents
Access to Genopole's scientific infrastructures and experts

Business support 📁

A business manager to assist you in structuring your business plan
An intensive workshop program with collective and individual sessions led by IP experts, law firms, consultants, etc.

Objectives 🎯

Generate initial data to obtain your proof of concept
Build your business plan and understand your market
Create your startup

Learn more 🎧

Clara Brouaux, Program manger, talks to you about Shaker in the BiotechNews podcast!

Which innovation sectors?

HealthTech

Biotherapies, medical devices, gene therapies, cell therapies, diagnostics, etc.

Bioeconomy

Synthetic biology, biomaterials, energies, foodtech, greentech, etc.

How To Participate?

Click on the button Participate on top right.

Create your account and accept the terms and conditions of Shaker, then you arrive at the first stage of challenge

You can come back to your candidate space many times as you want to modify you application file
One account per project (created by the project leader) but you can be more than one to lead the project.

About Genopole

Genopole, France’s leading biocluster for biotechnologies and research in genomics and genetics, unites innovative high-tech life sciences companies, public and private research and higher education facilities at a single site in Evry/Corbeil-Essonnes, just south of Paris.

Genopole is a pioneer in France.